13
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy

, , , , &
Pages 221-228 | Accepted 24 Mar 2000, Published online: 10 Jul 2009

References

  • Aksamit A J, Gendelman H E, Orenstein J M, Pezeshkpour G H. AIDS-associated progressive multifocal leukoencephalopathy (PML): comparison to non-AIDS PML with in situ hybridization and immunohisto-chemistry. Neurology 1990; 40: 1073–1078
  • Berger J R, Concha M. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J NeuroVirology 1995; 1: 5–18
  • Berger J R, Kaszovitz D, Post J D, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: a review of the literature with a report of sixteen cases. Ann Intern Med 1987; 107: 87
  • Bonwetsch R, Croul S, Richardson M W, Lorenzana C, Del Valle L, Sverstiuk A E, Amini S, Morgello S, Khalili K, Rappaport J. Role of HIV-1 Tat and CC chemokine MlP-la in the pathogenesis of HIV associated central nervous system disorders. J Neuro-virology 1999; 5: 685–694
  • Chowdhury M, Taylor J P, Tada H, Rappaport J, Wong-Staal F, Amini S, Khalili K. Regulation of the human neurotropic virus promoter by JCV T-antigen and HIV-1 Tat protein. Oncogene 1990; 5: 1737–1742
  • Chowdhury M, Taylor J P, Chang C-F, Rappaport J, Khalili K. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J Virol 1992; 66: 7355–7361
  • Chowdhury M, Kundu M, Khalili K. GC/GA rich sequence confers Tat-responsiveness to human neurotropic virus promoter, JCVL, in cells derived from CNS. Oncogene 1993; 8: 887–892
  • Frankel A D, Pabo C O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988; 55: 1189–1193
  • Hottiger M O, Nabel G J. Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. J Virol 1998; 72: 8252–8256
  • Krynska B, Gordon J, Otte J, Franks R, Knobler R, Giordano A, DeLuca A, Khalili K. Role of cell cycle regulators in tumor formation in transgenic mice expressing the human neurotropic virus, JCV, early protein. J Cell Biochem 1997; 67: 223–230
  • Kundu M, Guermah M, Roeder R G, Amini S, Khalili K. Interaction between cell cycle regulator, E2F-1, and NF-kappa B mediates repression of HIV-1 gene transcription. J Biol Chem 1997; 272: 29468–29474
  • Liu Y, Sune C, Garcia-Blanco M A. Human immunodeficiency virus type 1 Tat-dependent activation of an arrested RNA polymerase II elongation complex. Virology 1999; 255: 337–346
  • Nash A, Conant K, Chen P, Scott C, Major E O. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem 1999; 274: 17098–17102
  • Price R W, Sidtis J J, Brew B J. AIDS dementia complex and HIV-1 infection: a view from the clinic. Brain Pathol 1991; 1: 155–162
  • Sawaya B E, Thatikunta P, Denisova L, Brady J, Khalili K, Amini S. Regulation of TNFα and TGFβ-l gene transcription by HIV-1 Tat in CNS cells. J Neuroimmunol 1998; 87: 33–42
  • Tada H, Rappaport J, Amini S, Lashgari M, Wong-Stahl F, Khalili K. Cell type transactivation of human neurotropic virus JCV promoter by HIV-TAT protein. Proc Natl Acad Sci USA 1990; 87: 3479–3483
  • Walker D L. Progressive multifocal leukoencepha-lopathy. Handbook of Clinical Neurology, P J Vinken, et al. Elsevier Science Publishing, Inc., New York 1985; vol. 47: 503–524
  • Xiao H, Tao Y, Greenblatt J, Roeder R G. A cofactor, TEP30, specifically enhances HIV-1 Tat-activated transcription. Proc Natl Acad Sci USA 1998; 95: 2146–2151

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.